SLE-话题@MedSci

#SLE#

240篇内容 | 7436人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1345066, encodeId=1291134506674, content=<a href='/topic/show?id=cf721640495' target=_blank style='color:#2F92EE;'>#SLE#</a>, objectTitle=J Clin Oncol：RATIONALE-302研究证实Tislelizumab ( 替雷利珠单抗)二线治疗可改善晚期或转移性食管鳞状细胞癌（ESCC）患者的OS, objectType=article, longId=727477, objectId=0a19e27477f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a19e27477f4, replyNumber=0, likeNumber=0, createdTime=2022-05-22, rootId=0, userName=ms4657536712156177, userId=20872500216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a19e27477f4, moduleTitle=J Clin Oncol：RATIONALE-302研究证实Tislelizumab ( 替雷利珠单抗)二线治疗可改善晚期或转移性食管鳞状细胞癌（ESCC）患者的OS, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0a19e27477f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1345065, encodeId=5b831345065e1, content=<a href='/topic/show?id=cf721640495' target=_blank style='color:#2F92EE;'>#SLE#</a>, objectTitle=5.10 世界狼疮日丨这7个SLE诊疗陷阱，踩过的都后悔了, objectType=article, longId=726549, objectId=b495e265497e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b495e265497e, replyNumber=0, likeNumber=94, createdTime=2022-05-12, rootId=0, userName=ms4657536712156177, userId=20872500216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b495e265497e, moduleTitle=5.10 世界狼疮日丨这7个SLE诊疗陷阱，踩过的都后悔了, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b495e265497e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1345064, encodeId=42c4134506427, content=<a href='/topic/show?id=cf721640495' target=_blank style='color:#2F92EE;'>#SLE#</a>, objectTitle=Lupus：泰它西普对儿童期发病的SLE的效果与安全性观察：基于真实世界临床研究, objectType=article, longId=726453, objectId=c1a5e26453b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c1a5e26453b5, replyNumber=0, likeNumber=124, createdTime=2022-05-11, rootId=0, userName=ms4657536712156177, userId=20872500216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c1a5e26453b5, moduleTitle=Lupus：泰它西普对儿童期发病的SLE的效果与安全性观察：基于真实世界临床研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c1a5e26453b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1345063, encodeId=e8dd1345063e8, content=<a href='/topic/show?id=cf721640495' target=_blank style='color:#2F92EE;'>#SLE#</a>, objectTitle=J Immunother Cancer：Bempegaldesleukin联合纳武单抗一线治疗晚期肾细胞癌, objectType=article, longId=725499, objectId=bec0e25499db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bec0e25499db, replyNumber=0, likeNumber=185, createdTime=2022-04-28, rootId=0, userName=ms4657536712156177, userId=20872500216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bec0e25499db, moduleTitle=J Immunother Cancer：Bempegaldesleukin联合纳武单抗一线治疗晚期肾细胞癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bec0e25499db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1345062, encodeId=5758134506275, content=<a href='/topic/show?id=cf721640495' target=_blank style='color:#2F92EE;'>#SLE#</a>, objectTitle=百济神州的tislelizumab在中国再次获得批准, objectType=article, longId=724435, objectId=fa20e24435c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fa20e24435c4, replyNumber=0, likeNumber=0, createdTime=2022-04-18, rootId=0, userName=ms4657536712156177, userId=20872500216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fa20e24435c4, moduleTitle=百济神州的tislelizumab在中国再次获得批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fa20e24435c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1345061, encodeId=503e134506179, content=<a href='/topic/show?id=cf721640495' target=_blank style='color:#2F92EE;'>#SLE#</a>, objectTitle=SLE患者如何科学减激素？前沿激素减量指导！, objectType=article, longId=301886, objectId=dcfa301886c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dcfa301886c7, replyNumber=0, likeNumber=118, createdTime=2022-03-30, rootId=0, userName=ms4657536712156177, userId=20872500216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dcfa301886c7, moduleTitle=SLE患者如何科学减激素？前沿激素减量指导！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dcfa301886c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1345060, encodeId=943c134506040, content=<a href='/topic/show?id=cf721640495' target=_blank style='color:#2F92EE;'>#SLE#</a>, objectTitle=ARD：根据SLE患者I型干扰素基因特征和临床亚组分析Anifrolumab疗效和安全性：两项III期试验汇总数据的事后分析, objectType=article, longId=301850, objectId=439030185039, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=439030185039, replyNumber=0, likeNumber=122, createdTime=2022-03-30, rootId=0, userName=ms4657536712156177, userId=20872500216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=439030185039, moduleTitle=ARD：根据SLE患者I型干扰素基因特征和临床亚组分析Anifrolumab疗效和安全性：两项III期试验汇总数据的事后分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=439030185039)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1345059, encodeId=06e113450592f, content=<a href='/topic/show?id=cf721640495' target=_blank style='color:#2F92EE;'>#SLE#</a>, objectTitle=Sleep：这种药物可以有效改善女性盗汗失眠, objectType=article, longId=299520, objectId=8576299520ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8576299520ce, replyNumber=0, likeNumber=119, createdTime=2022-02-25, rootId=0, userName=ms4657536712156177, userId=20872500216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8576299520ce, moduleTitle=Sleep：这种药物可以有效改善女性盗汗失眠, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8576299520ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1345058, encodeId=110d134505802, content=<a href='/topic/show?id=cf721640495' target=_blank style='color:#2F92EE;'>#SLE#</a>, objectTitle=ARD：人类SLE变异NCF1-R90H通过巨噬细胞缺陷性的胞葬作用诱导Tfh2反应增强来促进肾损伤和鼠狼疮, objectType=article, longId=294402, objectId=41c329440201, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=41c329440201, replyNumber=0, likeNumber=111, createdTime=2022-01-22, rootId=0, userName=ms4657536712156177, userId=20872500216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=41c329440201, moduleTitle=ARD：人类SLE变异NCF1-R90H通过巨噬细胞缺陷性的胞葬作用诱导Tfh2反应增强来促进肾损伤和鼠狼疮, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=41c329440201)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1345057, encodeId=bc0f134505e4d, content=<a href='/topic/show?id=cf721640495' target=_blank style='color:#2F92EE;'>#SLE#</a>, objectTitle=Sleep：睡眠纺锤波可作为神经退行性疾病检测的生物标志物, objectType=article, longId=294318, objectId=e9bc2943186c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e9bc2943186c, replyNumber=0, likeNumber=73, createdTime=2022-01-21, rootId=0, userName=ms4657536712156177, userId=20872500216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e9bc2943186c, moduleTitle=Sleep：睡眠纺锤波可作为神经退行性疾病检测的生物标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e9bc2943186c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1345056, encodeId=66ed13450564d, content=<a href='/topic/show?id=cf721640495' target=_blank style='color:#2F92EE;'>#SLE#</a>, objectTitle=Sleep Medicine Reviews：哮喘与OSA的相互作用会加剧疾病的严重性, objectType=article, longId=292190, objectId=3eca2921905c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3eca2921905c, replyNumber=0, likeNumber=104, createdTime=2021-12-19, rootId=0, userName=ms4657536712156177, userId=20872500216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3eca2921905c, moduleTitle=Sleep Medicine Reviews：哮喘与OSA的相互作用会加剧疾病的严重性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3eca2921905c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1345055, encodeId=09c1134505503, content=<a href='/topic/show?id=cf721640495' target=_blank style='color:#2F92EE;'>#SLE#</a>, objectTitle=SLE罕见的首发表现——肠系膜血管炎, objectType=article, longId=220621, objectId=072f22062162, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=072f22062162, replyNumber=0, likeNumber=137, createdTime=2021-11-21, rootId=0, userName=ms4657536712156177, userId=20872500216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=072f22062162, moduleTitle=SLE罕见的首发表现——肠系膜血管炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=072f22062162)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1345054, encodeId=47b41345054a7, content=<a href='/topic/show?id=cf721640495' target=_blank style='color:#2F92EE;'>#SLE#</a>, objectTitle=Clin Cancer Res：Tislelizumab治疗复发/难治性经典霍奇金淋巴瘤的长期预后, objectType=article, longId=220359, objectId=d3e4220359a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d3e4220359a1, replyNumber=0, likeNumber=122, createdTime=2021-11-16, rootId=0, userName=ms4657536712156177, userId=20872500216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d3e4220359a1, moduleTitle=Clin Cancer Res：Tislelizumab治疗复发/难治性经典霍奇金淋巴瘤的长期预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d3e4220359a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1345053, encodeId=e4261345053aa, content=<a href='/topic/show?id=cf721640495' target=_blank style='color:#2F92EE;'>#SLE#</a>, objectTitle=Sleep：COVID-19封锁期间，晚上接触电子设备如何影响了我们的睡眠？, objectType=article, longId=220247, objectId=ad2622024e6e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad2622024e6e, replyNumber=0, likeNumber=149, createdTime=2021-11-14, rootId=0, userName=ms4657536712156177, userId=20872500216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad2622024e6e, moduleTitle=Sleep：COVID-19封锁期间，晚上接触电子设备如何影响了我们的睡眠？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ad2622024e6e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1345052, encodeId=95141345052d6, content=<a href='/topic/show?id=cf721640495' target=_blank style='color:#2F92EE;'>#SLE#</a>, objectTitle=Clin Cancer Res：Tislelizumab（替雷利珠单抗）治疗复发/难治性经典霍奇金淋巴瘤(cHL)患者疗效和安全性。, objectType=article, longId=220072, objectId=4ff72200e20b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4ff72200e20b, replyNumber=0, likeNumber=84, createdTime=2021-11-12, rootId=0, userName=ms4657536712156177, userId=20872500216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ff72200e20b, moduleTitle=Clin Cancer Res：Tislelizumab（替雷利珠单抗）治疗复发/难治性经典霍奇金淋巴瘤(cHL)患者疗效和安全性。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4ff72200e20b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1345051, encodeId=500f13450511c, content=<a href='/topic/show?id=cf721640495' target=_blank style='color:#2F92EE;'>#SLE#</a>, objectTitle=SLEEP：认知行为疗法不仅能治疗失眠，还能改善疲劳和功能！, objectType=article, longId=218910, objectId=a10e21891012, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a10e21891012, replyNumber=0, likeNumber=107, createdTime=2021-10-21, rootId=0, userName=ms4657536712156177, userId=20872500216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a10e21891012, moduleTitle=SLEEP：认知行为疗法不仅能治疗失眠，还能改善疲劳和功能！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a10e21891012)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1345050, encodeId=7f5f1345050fb, content=<a href='/topic/show?id=cf721640495' target=_blank style='color:#2F92EE;'>#SLE#</a>, objectTitle=Sleep and Breathing：未合并心血管疾病的轻度阻塞性睡眠呼吸暂停患者心脏影像学改变，OSA相关心血管疾病的一级预防不可忽视, objectType=article, longId=215859, objectId=f62a21585988, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f62a21585988, replyNumber=0, likeNumber=170, createdTime=2021-08-18, rootId=0, userName=ms4657536712156177, userId=20872500216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f62a21585988, moduleTitle=Sleep and Breathing：未合并心血管疾病的轻度阻塞性睡眠呼吸暂停患者心脏影像学改变，OSA相关心血管疾病的一级预防不可忽视, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f62a21585988)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1345049, encodeId=92161345049e3, content=<a href='/topic/show?id=cf721640495' target=_blank style='color:#2F92EE;'>#SLE#</a>, objectTitle=Arthritis Rheumatol：SLE患者接种SARS-CoV-2疫苗后免疫反应和疾病状态评估, objectType=article, longId=215391, objectId=d2552153912e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d2552153912e, replyNumber=0, likeNumber=113, createdTime=2021-08-08, rootId=0, userName=ms4657536712156177, userId=20872500216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d2552153912e, moduleTitle=Arthritis Rheumatol：SLE患者接种SARS-CoV-2疫苗后免疫反应和疾病状态评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d2552153912e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1345048, encodeId=6bed1345048cd, content=<a href='/topic/show?id=cf721640495' target=_blank style='color:#2F92EE;'>#SLE#</a>, objectTitle=SLEEP：完全睡眠剥夺的人情商低的原因可能在这, objectType=article, longId=215005, objectId=36df215005c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=36df215005c0, replyNumber=0, likeNumber=86, createdTime=2021-07-30, rootId=0, userName=ms4657536712156177, userId=20872500216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=36df215005c0, moduleTitle=SLEEP：完全睡眠剥夺的人情商低的原因可能在这, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=36df215005c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1345047, encodeId=5551134504ef7, content=<a href='/topic/show?id=cf721640495' target=_blank style='color:#2F92EE;'>#SLE#</a>, objectTitle=J Clin Oncol：Bempegaldesleukin 联合纳武利尤单抗（Nivolumab）一线治疗转移性黑色素瘤, objectType=article, longId=214261, objectId=08ac21426112, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=08ac21426112, replyNumber=0, likeNumber=63, createdTime=2021-07-17, rootId=0, userName=ms4657536712156177, userId=20872500216, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=08ac21426112, moduleTitle=J Clin Oncol：Bempegaldesleukin 联合纳武利尤单抗（Nivolumab）一线治疗转移性黑色素瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=08ac21426112)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

SLE

2020-05-29

ms4657536712156177 (审核中...)

前往app查看评论内容

#SLE#

J Clin Oncol：RATIONALE-302研究证实Tislelizumab ( 替雷利珠单抗)二线治疗可改善晚期或转移性食管鳞状细胞癌（ESCC）患者的OS

2022-05-22

ms4657536712156177 (审核中...)

前往app查看评论内容

#SLE#

5.10 世界狼疮日丨这7个SLE诊疗陷阱，踩过的都后悔了

2022-05-12

ms4657536712156177 (审核中...)

前往app查看评论内容

#SLE#

Lupus：泰它西普对儿童期发病的SLE的效果与安全性观察：基于真实世界临床研究

2022-05-11

ms4657536712156177 (审核中...)

前往app查看评论内容

#SLE#

J Immunother Cancer：Bempegaldesleukin联合纳武单抗一线治疗晚期肾细胞癌

2022-04-28

ms4657536712156177 (审核中...)

前往app查看评论内容

#SLE#

百济神州的tislelizumab在中国再次获得批准

2022-04-18

ms4657536712156177 (审核中...)

前往app查看评论内容

#SLE#

SLE患者如何科学减激素？前沿激素减量指导！

2022-03-30

ms4657536712156177 (审核中...)

前往app查看评论内容

#SLE#

ARD：根据SLE患者I型干扰素基因特征和临床亚组分析Anifrolumab疗效和安全性：两项III期试验汇总数据的事后分析

2022-03-30

ms4657536712156177 (审核中...)

前往app查看评论内容

#SLE#

Sleep：这种药物可以有效改善女性盗汗失眠

2022-02-25

ms4657536712156177 (审核中...)

前往app查看评论内容

#SLE#

ARD：人类SLE变异NCF1-R90H通过巨噬细胞缺陷性的胞葬作用诱导Tfh2反应增强来促进肾损伤和鼠狼疮

2022-01-22

ms4657536712156177 (审核中...)

前往app查看评论内容

#SLE#

Sleep：睡眠纺锤波可作为神经退行性疾病检测的生物标志物

2022-01-21

ms4657536712156177 (审核中...)

前往app查看评论内容

#SLE#

Sleep Medicine Reviews：哮喘与OSA的相互作用会加剧疾病的严重性

2021-12-19

ms4657536712156177 (审核中...)

前往app查看评论内容

#SLE#

SLE罕见的首发表现——肠系膜血管炎

2021-11-21

ms4657536712156177 (审核中...)

前往app查看评论内容

#SLE#

Clin Cancer Res：Tislelizumab治疗复发/难治性经典霍奇金淋巴瘤的长期预后

2021-11-16

ms4657536712156177 (审核中...)

前往app查看评论内容

#SLE#

Sleep：COVID-19封锁期间，晚上接触电子设备如何影响了我们的睡眠？

2021-11-14

ms4657536712156177 (审核中...)

前往app查看评论内容

#SLE#

Clin Cancer Res：Tislelizumab（替雷利珠单抗）治疗复发/难治性经典霍奇金淋巴瘤(cHL)患者疗效和安全性。

2021-11-12

ms4657536712156177 (审核中...)

前往app查看评论内容

#SLE#

SLEEP：认知行为疗法不仅能治疗失眠，还能改善疲劳和功能！

2021-10-21

ms4657536712156177 (审核中...)

前往app查看评论内容

#SLE#

Sleep and Breathing：未合并心血管疾病的轻度阻塞性睡眠呼吸暂停患者心脏影像学改变，OSA相关心血管疾病的一级预防不可忽视

2021-08-18

ms4657536712156177 (审核中...)

前往app查看评论内容

#SLE#

Arthritis Rheumatol：SLE患者接种SARS-CoV-2疫苗后免疫反应和疾病状态评估

2021-08-08

ms4657536712156177 (审核中...)

前往app查看评论内容

#SLE#

SLEEP：完全睡眠剥夺的人情商低的原因可能在这

2021-07-30

ms4657536712156177 (审核中...)

前往app查看评论内容

#SLE#

J Clin Oncol：Bempegaldesleukin 联合纳武利尤单抗（Nivolumab）一线治疗转移性黑色素瘤

2021-07-17

科室
- - 订阅+
  - 更多科室
工具
服务